BIOTECH ACQUISITION COMPANY Increase (Decrease) in Derivative Liabilities
BIOTECH ACQUISITION COMPANY reported Increase (Decrease) in Derivative Liabilities of -$17.46 million for the 9-month period ending 2022-09-30, per its 10-Q filed 2022-11-22.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInDerivativeLiabilities · last filed 2022-11-22
- BIOTECH ACQUISITION COMPANY increase (decrease) in derivative liabilities for the quarter ending 2022-09-30 was -$492.75K.
- BIOTECH ACQUISITION COMPANY increase (decrease) in derivative liabilities for the quarter ending 2022-06-30 was -$10.41M, a 325.84% decline year-over-year.
- BIOTECH ACQUISITION COMPANY increase (decrease) in derivative liabilities for the quarter ending 2022-03-31 was -$6.55M.
- BIOTECH ACQUISITION COMPANY increase (decrease) in derivative liabilities for the quarter ending 2021-12-31 was $6.96M.
- BIOTECH ACQUISITION COMPANY increase (decrease) in derivative liabilities for fiscal 2021 was $4.80M.
| Period end | Increase (Decrease) in Derivative Liabilities 3 month | Increase (Decrease) in Derivative Liabilities 6 month | Increase (Decrease) in Derivative Liabilities 9 month | Increase (Decrease) in Derivative Liabilities 12 month |
|---|---|---|---|---|
| 2022-09-30 | -$492.75K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-22 | -$10.90M derived: sum of 2 quarters · filed 2022-11-22 | -$17.46M 10-Q · filed 2022-11-22 | -$10.50M derived: sum of 4 quarters · filed 2022-11-22 |
| 2022-06-30 | -$10.41M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-22 | -$16.97M 10-Q · filed 2022-08-22 | -$10.00M derived: sum of 3 quarters · filed 2022-08-22 | -$13.57M derived: sum of 4 quarters · filed 2022-11-22 |
| 2022-03-31 | -$6.55M 10-Q · filed 2022-05-16 | $407.62K derived: sum of 2 quarters · filed 2022-05-16 | -$3.16M derived: sum of 3 quarters · filed 2022-11-22 | $1.45M derived: sum of 4 quarters · filed 2022-11-22 |
| 2021-12-31 | $6.96M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-08 | $3.40M derived: sum of 2 quarters · filed 2022-11-22 | $8.01M derived: sum of 3 quarters · filed 2022-11-22 | $4.80M 10-K · filed 2022-03-08 |
| 2021-09-30 | -$3.57M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-22 | $1.04M derived: sum of 2 quarters · filed 2022-11-22 | -$2.17M 10-Q · filed 2022-11-22 | |
| 2021-06-30 | $4.61M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-22 | $1.40M 10-Q · filed 2022-08-22 | ||
| 2021-03-31 | -$3.21M 10-Q · filed 2022-05-16 |